Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025
Akero Therapeutics (NASDAQ: AKRO) presented new analyses of their Phase 2b HARMONY...
Akero Therapeutics (NASDAQ: AKRO) presented new analyses of their Phase 2b HARMONY...
The rise of blockchain has fundamentally reshaped the financial ecosystem. Since Bitcoin’s genesis in 2009, permissionless blockchains have introduced an...
Kelexo (KLXO) is a pioneer of DeFi innovation, with presales available in phase 2, offering an AI-powered peer-to-peer lending and...
What I hope in the end is just they do the right thing to make the product better and set...
The crypto space is one of the most inclusive and diverse workplaces for people from across the globe. Companies prospering...
After severe boom and bust phases, how can we gauge the importance of blockchain-based assets? Will they interface with daily...
Kolahon, which translates to ‘chaos’ in Thai, is not just a name but a representation of the nimble balance between...
Late last night, the attackers behind the Harmony exploit back in June 2022 attempted to cash out another batch of...
Arman Shirinyan Hackers trying to make stolen funds useful again, but some part should be safe now Funds from the...
North Korean exploiters behind the Harmony Bridge attack continue to launder the funds stolen in June 2022. According to on-chain...